Hefei Lifeon Pharmaceutical Co., Ltd. (SHE:003020)
China flag China · Delayed Price · Currency is CNY
26.03
-0.50 (-1.88%)
At close: Feb 12, 2026

SHE:003020 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Operating Revenue
1,4441,4881,8872,5702,2611,882
Other Revenue
30.3230.3214.258.8611.7712.73
1,4741,5181,9012,5792,2731,894
Revenue Growth (YoY)
-1.82%-20.11%-26.31%13.46%20.01%14.80%
Cost of Revenue
524479.46932.111,6191,3691,262
Gross Profit
950.051,039968.68960.28904.36632.6
Selling, General & Admin
687.93772.94659.7675.31650.1432.84
Research & Development
109.0191.7884.9673.865.8643.31
Other Operating Expenses
24.4219.3114.9715.9616.0612.39
Operating Expenses
823.49887.09762.82765.5731.99489.05
Operating Income
126.56151.94205.85194.78172.36143.55
Interest Expense
-2.08-1.92-1.28-0.89-1.36-0.24
Interest & Investment Income
31.8513.6232.1436.6814.584.3
Currency Exchange Gain (Loss)
0.010.010.040.4-0.18-0.49
Other Non Operating Income (Expenses)
-0.7-0.750.92-0.17-0.34-0.15
EBT Excluding Unusual Items
155.64162.9237.67230.81185.06146.96
Gain (Loss) on Sale of Investments
0.441.60.32-0.04-0.01-
Gain (Loss) on Sale of Assets
-0.130.02--2.54-0.03-0.03
Asset Writedown
-6.97-6.43-0.12-0.39-0.27-0.06
Other Unusual Items
28.3813.7219.5511.9810.0910.07
Pretax Income
177.36171.82257.42239.82194.84156.94
Income Tax Expense
17.4219.3423.5330.5722.6121.82
Earnings From Continuing Operations
159.94152.48233.88209.25172.23135.12
Minority Interest in Earnings
2.628.12-7.21---
Net Income
162.56160.6226.67209.25172.23135.12
Net Income to Common
162.56160.6226.67209.25172.23135.12
Net Income Growth
-6.72%-29.15%8.33%21.50%27.47%28.51%
Shares Outstanding (Basic)
191191192189188141
Shares Outstanding (Diluted)
191191192189188141
Shares Change (YoY)
-0.64%-0.47%1.75%0.49%33.01%0.03%
EPS (Basic)
0.850.841.181.110.920.96
EPS (Diluted)
0.850.841.181.110.920.96
EPS Growth
-6.13%-28.81%6.47%20.90%-4.17%28.47%
Free Cash Flow
121.4143.056.14-45.79-28.24116.29
Free Cash Flow Per Share
0.640.230.03-0.24-0.150.82
Dividend Per Share
0.5000.5000.4170.3210.3450.246
Dividend Growth
-18.92%19.99%30.02%-7.16%40.04%-
Gross Margin
64.45%68.42%50.96%37.23%39.78%33.40%
Operating Margin
8.59%10.01%10.83%7.55%7.58%7.58%
Profit Margin
11.03%10.58%11.92%8.11%7.58%7.13%
Free Cash Flow Margin
8.24%2.83%0.32%-1.77%-1.24%6.14%
EBITDA
230.87226.84241.56220.72199.92159.5
EBITDA Margin
15.66%14.94%12.71%8.56%8.79%8.42%
D&A For EBITDA
104.374.9135.7125.9427.5515.95
EBIT
126.56151.94205.85194.78172.36143.55
EBIT Margin
8.59%10.01%10.83%7.55%7.58%7.58%
Effective Tax Rate
9.82%11.25%9.14%12.75%11.60%13.91%
Revenue as Reported
1,4741,5181,9012,5792,2731,894
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.